{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:14:48Z","timestamp":1791213288470,"version":"4.1.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLB) and Parkinson\u2019s disease dementia (PDD), is characterized by cognitive decline, sleep disturbances, motor dysfunction, and other debilitating clinical symptoms. Neuropathologically, LBD is characterized by the progressive accumulation of alpha-synuclein (aSYN) in vulnerable cellular populations in the brain. Diagnosing LBD is challenging due to the overlap of clinical symptoms with Alzheimer\u2019s disease (AD) and other neurodegenerative disorders with current diagnostic tools, including clinical examinations by specialized neurologists and brain imaging, limited by accessibility. Taken together, LBD is often misdiagnosed, especially at early disease stages. Seed amplification assays to detect pathogenic aSYN (aSYN SAAs) are emerging as promising tools to detect aSYN pathology in biological specimens. These assays amplify trace amounts of misfolded aSYN, enabling their potential detection in brain, CSF, saliva, skin, and blood. This review compares the sensitivity and specificity of aSYN SAAs across different biological samples and explores the potential of the assay as a diagnostic in LBD. We also highlight challenges that will need to be addressed going forward if the aSYN SAA is to be widely adopted as a diagnostic test. Despite current limitations, aSYN SAAs hold promise for early and precise diagnosis, paving the way for targeted treatments that could significantly improve patient care and outcomes.<\/jats:p>","DOI":"10.1186\/s13024-025-00868-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:00:40Z","timestamp":1751364040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Alpha-synuclein seeding amplification assays in Lewy body dementia: a brief review"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1125-7890","authenticated-orcid":false,"given":"Maria","family":"Bregendahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Bengisu","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"868_CR1","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. Lancet. 2015;386:1683\u201397.","journal-title":"Lancet"},{"key":"868_CR2","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/03007995.2022.2059978","volume":"38","author":"U Desai","year":"2022","unstructured":"Desai U, Chandler J, Kirson N, Georgieva M, Cheung CH, Westermeyer B, Lane H, Biglan K. Epidemiology and economic burden of Lewy body dementia in the United States. Curr Med Res Opin. 2022;38:1177\u201388.","journal-title":"Curr Med Res Opin"},{"key":"868_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00019052-200108000-00001","volume":"14","author":"DW Dickson","year":"2001","unstructured":"Dickson DW. Alpha-synuclein and the Lewy body disorders. Curr Opin Neurol. 2001;14:423\u201332.","journal-title":"Curr Opin Neurol"},{"key":"868_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW. Neuropathology and molecular diagnosis of Synucleinopathies. Mol Neurodegener. 2021;16:83.","journal-title":"Mol Neurodegener"},{"key":"868_CR5","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","volume":"20","author":"DD Murphy","year":"2000","unstructured":"Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci. 2000;20:3214\u201320.","journal-title":"J Neurosci"},{"key":"868_CR6","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1038\/sj.emboj.7600451","volume":"23","author":"S Liu","year":"2004","unstructured":"Liu S, Ninan I, Antonova I, Battaglia F, Trinchese F, Narasanna A, Kolodilov N, Dauer W, Hawkins RD, Arancio O. Alpha-synuclein produces a long-lasting increase in neurotransmitter release. Embo J. 2004;23:4506\u201316.","journal-title":"Embo J"},{"key":"868_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M. Alpha-synuclein RT-Qu IC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol. 2016;3:812\u20138.","journal-title":"Ann Clin Transl Neurol"},{"key":"868_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz M, Tokuda T, Waragai M, M\u00e9ndez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C. Development of a biochemical diagnosis of parkinson disease by detection of \u0391-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol. 2017;74:163.","journal-title":"JAMA Neurol"},{"key":"868_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ana.25824","volume":"88","author":"W Singer","year":"2020","unstructured":"Singer W, Schmeichel AM, Shahnawaz M, Schmelzer JD, Boeve BF, Sletten DM, Gehrking TL, Gehrking JA, Olson AD, Savica R. Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from Lewy body synucleinopathies. Ann Neurol. 2020;88:503\u201312.","journal-title":"Ann Neurol"},{"key":"868_CR10","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/brain\/awac115","volume":"145","author":"A Kluge","year":"2022","unstructured":"Kluge A, Bunk J, Schaeffer E, Drobny A, Xiang W, Knacke H, Bub S, L\u00fcckst\u00e4dt W, Arnold P, Lucius R, et al. Detection of neuron-derived pathological \u03b1-synuclein in blood. Brain. 2022;145:3058\u201371.","journal-title":"Brain"},{"key":"868_CR11","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/mds.29766","volume":"39","author":"A Kluge","year":"2024","unstructured":"Kluge A, Schaeffer E, Bunk J, Sommerauer M, R\u00f6ttgen S, Schulte C, Roeben B, von Thaler AK, Welzel J, Lucius R, et al. Detecting misfolded \u03b1-Synuclein in blood years before the diagnosis of Parkinson\u2019s disease. Mov Disord. 2024;39:1289\u201399.","journal-title":"Mov Disord"},{"key":"868_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, et al. A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 2024;23:178\u201390.","journal-title":"Lancet Neurol"},{"key":"868_CR13","unstructured":"H\u00f6glinger GU, Lang AE. SynNeurGe: the road ahead for a biological definition of Parkinson's disease. J Parkinson\u2019s Dis. 0:1877718X241298194."},{"key":"868_CR14","first-page":"435","volume":"22","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN. Lewy body dementias: dementia with lewy bodies and Parkinson disease dementia. Continuum (Minneap Minn). 2016;22:435\u201363.","journal-title":"Continuum (Minneap Minn)"},{"key":"868_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA Deture","year":"2019","unstructured":"Deture MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:32.","journal-title":"Mol Neurodegener"},{"key":"868_CR16","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1212\/01.WNL.0000066054.20031.B0","volume":"60","author":"CF Lippa","year":"2003","unstructured":"Lippa CF, McKeith I. Dementia with Lewy bodies. Neurology. 2003;60:1571\u20133.","journal-title":"Neurology"},{"key":"868_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archneur.59.1.102","volume":"59","author":"H Apaydin","year":"2002","unstructured":"Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol. 2002;59:102\u201312.","journal-title":"Arch Neurol"},{"key":"868_CR18","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag A-E, Lang AE. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.","journal-title":"Nat Rev Dis Primers"},{"key":"868_CR19","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614\u201329.","journal-title":"Lancet Neurol"},{"key":"868_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009921","volume":"17","author":"V Girard","year":"2021","unstructured":"Girard V, Jollivet F, Knittelfelder O, Celle M, Arsac JN, Chatelain G, Van den Brink DM, Baron T, Shevchenko A, Kuhnlein RP, et al. Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-Synuclein to proteolytic resistant forms in a Drosophila model of Parkinson\u2019s disease. PLoS Genet. 2021;17: e1009921.","journal-title":"PLoS Genet"},{"key":"868_CR21","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord. 2007;22:1689\u2013707. quiz 1837.","journal-title":"Mov Disord"},{"key":"868_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89:88\u2013100.","journal-title":"Neurology"},{"key":"868_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-018-8892-x","volume":"266","author":"T Yousaf","year":"2019","unstructured":"Yousaf T, Dervenoulas G, Valkimadi PE, Politis M. Neuroimaging in Lewy body dementia. J Neurol. 2019;266:1\u201326.","journal-title":"J Neurol"},{"key":"868_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.nicl.2018.09.012","volume":"20","author":"JJ Lloyd","year":"2018","unstructured":"Lloyd JJ, Petrides G, Donaghy PC, Colloby SJ, Attems J, O\u2019Brien JT, Roberts G, Thomas AJ. A new visual rating scale for Ioflupane imaging in Lewy body disease. Neuroimage Clin. 2018;20:823\u20139.","journal-title":"Neuroimage Clin"},{"key":"868_CR25","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","volume":"62","author":"Z Walker","year":"2004","unstructured":"Walker Z, Costa D, Walker R, Lee L, Livingston G, Jaros E, Perry R, McKeith I, Katona C. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology. 2004;62:1568\u201372.","journal-title":"Neurology"},{"key":"868_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/WAD.0000000000000414","volume":"35","author":"MJ Armstrong","year":"2021","unstructured":"Armstrong MJ, Irwin DJ, Leverenz JB, Gamez N, Taylor A, Galvin JE. Biomarker use for dementia with Lewy body diagnosis: survey of US experts. Alzheimer Dis Assoc Disord. 2021;35:55\u201361.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"868_CR27","doi-asserted-by":"publisher","first-page":"fcae148","DOI":"10.1093\/braincomms\/fcae148","volume":"6","author":"T Miyamoto","year":"2024","unstructured":"Miyamoto T, Miyamoto M. Reduced cardiac 123I-MIBG uptake is a robust biomarker of Lewy body disease in isolated rapid eye movement sleep behaviour disorder. Brain Commun. 2024;6:fcae148.","journal-title":"Brain Commun"},{"key":"868_CR28","doi-asserted-by":"crossref","unstructured":"Stylianou M, Murphy N, Peraza LR, Graziadio S, Cromarty R, Killen A, JT OB, Thomas AJ, Lebeau FEN, Taylor JP. Quantitative electroencephalography as a marker of cognitive fluctuations in dementia with Lewy bodies and an aid to differential diagnosis. Clin Neurophysiol. 2018;129:1209-1220","DOI":"10.1016\/j.clinph.2018.03.013"},{"key":"868_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, et al. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010;6:131\u201344.","journal-title":"Nat Rev Neurol"},{"key":"868_CR30","doi-asserted-by":"crossref","unstructured":"Hansson Oea. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. 2006;5:228-234.","DOI":"10.1016\/S1474-4422(06)70355-6"},{"key":"868_CR31","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","volume":"18","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L, Pritzkow S, Shahnawaz M, Farris CM, Soto C. Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat Protoc. 2023;18:1179\u201396.","journal-title":"Nat Protoc"},{"key":"868_CR32","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/mds.28651","volume":"36","author":"A Mammana","year":"2021","unstructured":"Mammana A, Baiardi S, Quadalti C, Rossi M, Donadio V, Capellari S, Liguori R, Parchi P. RT-QuIC detection of pathological \u03b1-Synuclein in skin punches of patients with Lewy body disease. Mov Disord. 2021;36:2173\u20137.","journal-title":"Mov Disord"},{"key":"868_CR33","unstructured":"Amprion's SAAmplify-\u0251SYN Test - Diagnostic Test For LBD & Parkinson's. https:\/\/ampriondx.com\/."},{"key":"868_CR34","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95:13363\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"868_CR35","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/370471a0","volume":"370","author":"DA Kocisko","year":"1994","unstructured":"Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B. Cell-free formation of protease-resistant prion protein. Nature. 1994;370:471\u20134.","journal-title":"Nature"},{"key":"868_CR36","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 2001;411:810\u20133.","journal-title":"Nature"},{"key":"868_CR37","doi-asserted-by":"publisher","first-page":"e1001277","DOI":"10.1371\/journal.ppat.1001277","volume":"7","author":"N Gonzalez-Montalban","year":"2011","unstructured":"Gonzalez-Montalban N, Makarava N, Ostapchenko GV, Savtchenk R, Alexeeva I, Rohwer GR, Baskakov VI. Highly efficient protein misfolding cyclic amplification. PLoS Pathog. 2011;7:e1001277.","journal-title":"PLoS Pathog"},{"key":"868_CR38","doi-asserted-by":"publisher","unstructured":"Saunders ES, Bartz CJ, Shikiya AR. Protein misfolding cyclic amplification of prions. J Vis Exp. 2012;(69):4075.\u00a0PMID: 23168797. https:\/\/doi.org\/10.3791\/4075.","DOI":"10.3791\/4075"},{"key":"868_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamanaka H, Shirabe S, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17:175\u20138.","journal-title":"Nat Med"},{"key":"868_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cell.2005.02.011","volume":"121","author":"J Castilla","year":"2005","unstructured":"Castilla J, Sa\u00e1 P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell. 2005;121:195\u2013206.","journal-title":"Cell"},{"key":"868_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00441-021-03568-8","volume":"392","author":"R Atarashi","year":"2023","unstructured":"Atarashi R. RT-QuIC as ultrasensitive method for prion detection. Cell Tissue Res. 2023;392:295\u2013300.","journal-title":"Cell Tissue Res"},{"key":"868_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3201\/eid2601.181423","volume":"26","author":"L Concha-Marambio","year":"2020","unstructured":"Concha-Marambio L, Chacon MA, Soto C. Preclinical detection of prions in blood of nonhuman primates infected with variant Creutzfeldt-Jakob disease. Emerg Infect Dis. 2020;26:34\u201343.","journal-title":"Emerg Infect Dis"},{"key":"868_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40478-023-01676-w","volume":"11","author":"B Frey","year":"2023","unstructured":"Frey B, Holzinger D, Taylor K, Ehrnhoefer DE, Striebinger A, Biesinger S, Gasparini L, O\u2019Neill MJ, Wegner F, Barghorn S, et al. Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer\u2019s disease brain. Acta Neuropathol Commun. 2023;11:181.","journal-title":"Acta Neuropathol Commun"},{"key":"868_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41531-024-00728-9","volume":"10","author":"IL Dellarole","year":"2024","unstructured":"Dellarole IL, Vacchi E, Ruiz-Barrio I, Pinton S, Raimondi A, Rossi S, Morandi S, Bianco G, Begum Bacinoglu M, Lombardo A, et al. Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies. NPJ Parkinsons Dis. 2024;10:116.","journal-title":"NPJ Parkinsons Dis"},{"key":"868_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X, Hu B, Schmeichel A, Singer W, Wu G, et al. Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature. 2020;578:273\u20137.","journal-title":"Nature"},{"key":"868_CR46","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH. The function of \u03b1-synuclein. Neuron. 2013;79:1044\u201366.","journal-title":"Neuron"},{"key":"868_CR47","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/ijms25020986","volume":"25","author":"K Nordengen","year":"2024","unstructured":"Nordengen K, Morland C. From synaptic physiology to synaptic pathology: the Enigma of \u03b1-Synuclein. Int J Mol Sci. 2024;25:986.","journal-title":"Int J Mol Sci"},{"key":"868_CR48","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/0092-8674(93)90635-4","volume":"73","author":"JT Jarrett","year":"1993","unstructured":"Jarrett JT, Lansbury PT Jr. Seeding \u201cone-dimensional crystallization\u201d of amyloid: a pathogenic mechanism in Alzheimer\u2019s disease and scrapie? Cell. 1993;73:1055\u20138.","journal-title":"Cell"},{"key":"868_CR49","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/aww230","volume":"140","author":"M Goedert","year":"2016","unstructured":"Goedert M, Masuda-Suzukake M, Falcon B. Like prions: the propagation of aggregated tau and \u03b1-synuclein in neurodegeneration. Brain. 2016;140:266\u201378.","journal-title":"Brain"},{"key":"868_CR50","doi-asserted-by":"crossref","unstructured":"Jahabardeen A, S N, J N, V C. A review on the role of SNCA gene in neurodegenerative diseases. Cureus 2024;16:e69450","DOI":"10.7759\/cureus.69450"},{"key":"868_CR51","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1172\/JCI127330","volume":"129","author":"RE Musgrove","year":"2019","unstructured":"Musgrove RE, Helwig M, Bae EJ, Aboutalebi H, Lee SJ, Ulusoy A, Di Monte DA. Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular \u03b1-synuclein transfer. J Clin Invest. 2019;129:3738\u201353.","journal-title":"J Clin Invest"},{"key":"868_CR52","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1172\/JCI130351","volume":"129","author":"KC Luk","year":"2019","unstructured":"Luk KC. Oxidative stress and \u03b1-synuclein conspire in vulnerable neurons to promote Parkinson\u2019s disease progression. J Clin Invest. 2019;129:3530\u20131.","journal-title":"J Clin Invest"},{"key":"868_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.690293","volume":"13","author":"NO Manzanza","year":"2021","unstructured":"Manzanza NO, Sedlackova L, Kalaria RN. Alpha-synuclein post-translational modifications: implications for pathogenesis of Lewy body disorders. Front Aging Neurosci. 2021;13: 690293.","journal-title":"Front Aging Neurosci"},{"key":"868_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.661117","volume":"12","author":"R Bell","year":"2021","unstructured":"Bell R, Vendruscolo M. Modulation of the interactions between \u03b1-Synuclein and lipid membranes by post-translational modifications. Front Neurol. 2021;12: 661117.","journal-title":"Front Neurol"},{"key":"868_CR55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109617119","volume":"119","author":"SS Ghanem","year":"2022","unstructured":"Ghanem SS, Majbour NK, Vaikath NN, Ardah MT, Erskine D, Jensen NM, Fayyad M, Sudhakaran IP, Vasili E, Melachroinou K, et al. \u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proc Natl Acad Sci. 2022;119: e2109617119.","journal-title":"Proc Natl Acad Sci"},{"key":"868_CR56","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11481-019-09835-4","volume":"14","author":"S Manne","year":"2019","unstructured":"Manne S, Kondru N, Hepker M, Jin H, Anantharam V, Lewis M, Huang X, Kanthasamy A, Kanthasamy AG. Ultrasensitive detection of aggregated \u03b1-Synuclein in glial cells, human cerebrospinal fluid, and brain tissue using the RT-QuIC assay: new high-throughput neuroimmune biomarker assay for Parkinsonian disorders. J Neuroimmune Pharmacol. 2019;14:423\u201335.","journal-title":"J Neuroimmune Pharmacol"},{"key":"868_CR57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00401-023-02663-0","volume":"147","author":"GM Bentivenga","year":"2024","unstructured":"Bentivenga GM, Mammana A, Baiardi S, Rossi M, Ticca A, Magliocchetti F, Mastrangelo A, Poleggi A, Ladogana A, Capellari S, Parchi P. Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden. Acta Neuropathol. 2024;147:18.","journal-title":"Acta Neuropathol"},{"key":"868_CR58","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3233\/JPD-230390","volume":"14","author":"E Schaeffer","year":"2024","unstructured":"Schaeffer E, Kluge A, Schulte C, Deuschle C, Bunk J, Welzel J, Maetzler W, Berg D. Association of misfolded \u03b1-Synuclein derived from neuronal exosomes in blood with Parkinson\u2019s disease diagnosis and duration. J Parkinsons Dis. 2024;14:667\u201379.","journal-title":"J Parkinsons Dis"},{"key":"868_CR59","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1212\/WNL.0000000000004146","volume":"89","author":"V Donadio","year":"2017","unstructured":"Donadio V, Incensi A, Rizzo G, Capellari S, Pantieri R, Maserati SM, Devigili G, Eleopra R, Defazio G, Montini F, et al. A new potential biomarker for dementia with Lewy bodies. Neurology. 2017;89:318\u201326.","journal-title":"Neurology"},{"key":"868_CR60","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mds.29340","volume":"38","author":"A Kuzkina","year":"2023","unstructured":"Kuzkina A, Panzer C, Seger A, Schmitt D, R\u00f6\u00dfle J, Schreglmann RS, Knacke H, Salabasidou E, Kohl A, Sittig E, et al. Dermal real-time quaking-induced conversion is a sensitive marker to confirm isolated rapid eye movement sleep behavior disorder as an early \u03b1-Synucleinopathy. Mov Disord. 2023;38:1077\u201382.","journal-title":"Mov Disord"},{"key":"868_CR61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamaneurol.2020.3311","volume":"78","author":"Z Wang","year":"2021","unstructured":"Wang Z, Becker K, Donadio V, Siedlak S, Yuan J, Rezaee M, Incensi A, Kuzkina A, Orr\u00fa CD, Tatsuoka C, et al. Skin \u03b1-Synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. JAMA Neurol. 2021;78:30\u201340.","journal-title":"JAMA Neurol"},{"key":"868_CR62","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.27907","volume":"35","author":"S Manne","year":"2019","unstructured":"Manne S, Kondru N, Jin H, Anantharam V, Huang X, Kanthasamy AG. \u0391-synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson\u2019s disease patients. Mov Disord. 2019;35:268\u201378.","journal-title":"Mov Disord"},{"key":"868_CR63","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/mds.28976","volume":"37","author":"M Luan","year":"2022","unstructured":"Luan M, Sun Y, Chen J, Jiang Y, Li F, Wei L, Sun W, Ma J, Lu S, Liu J, et al. Diagnostic value of salivary real-time quaking-induced conversion in Parkinson\u2019s disease and multiple system atrophy. Mov Disord. 2022;37:1059\u201363.","journal-title":"Mov Disord"},{"key":"868_CR64","doi-asserted-by":"publisher","unstructured":"Perra D, Bongianni M, Novi G, Janes F, Bessi V, Capaldi S, Sacchetto L, Tagliapietra M, Schenone G, Morbelli S, et al. Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies. Brain Commun. 2021;3(2):fcab045.\u00a0PMID: 33870192. https:\/\/doi.org\/10.1093\/braincomms\/fcab045.","DOI":"10.1093\/braincomms\/fcab045"},{"key":"868_CR65","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/brain\/awab005","volume":"144","author":"A Stefani","year":"2021","unstructured":"Stefani A, Iranzo A, Holzknecht E, Perra D, Bongianni M, Gaig C, Heim B, Serradell M, Sacchetto L, Garrido A, et al. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. Brain. 2021;144:1118\u201326.","journal-title":"Brain"},{"key":"868_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman BR, Orr\u00f9 CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B, Campbell KJ, Safar J, Galasko D, Caughey B. Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC. Acta Neuropathol Commun. 2018;6:7.","journal-title":"Acta Neuropathol Commun"},{"key":"868_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001217","volume":"6","author":"JM Wilham","year":"2010","unstructured":"Wilham JM, Orr\u00fa CD, Bessen RA, Atarashi R, Sano K, Race B, Meade-White KD, Taubner LM, Timmes A, Caughey B. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. 2010;6: e1001217.","journal-title":"PLoS Pathog"},{"key":"868_CR68","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/v8050140","volume":"8","author":"CD Orr\u00fa","year":"2016","unstructured":"Orr\u00fa CD, Hughson AG, Groveman BR, Campbell KJ, Anson KJ, Manca M, Kraus A, Caughey B. Factors that improve RT-QuIC detection of prion seeding activity. Viruses. 2016;8:140.","journal-title":"Viruses"},{"key":"868_CR69","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40478-021-01175-w","volume":"9","author":"C Bargar","year":"2021","unstructured":"Bargar C, Wang W, Gunzler AS, Lefevre A, Wang Z, Lerner JA, Singh N, Tatsuoka C, Appleby B, Zhu X, et al. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathologica Communications. 2021;9:62.","journal-title":"Acta Neuropathologica Communications"},{"key":"868_CR70","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/pro.2088","volume":"21","author":"L Kang","year":"2012","unstructured":"Kang L, Moriarty GM, Woods LA, Ashcroft AE, Radford SE, Baum J. N-terminal acetylation of \u03b1-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer. Protein Sci. 2012;21:911\u20137.","journal-title":"Protein Sci"},{"key":"868_CR71","doi-asserted-by":"crossref","unstructured":"Al-Azzawi ZAM, Silver NRG, Niu S, Luo W, Shlaifer I, Ingelsson M, Hyman BT, Trempe J-F, Durcan T, Watts JC, Fon EA. \u03b1-Synuclein purification significantly impacts seed amplification assay performance and consistency. bioRxiv. 2025:2025.2005.2008.652548.","DOI":"10.1101\/2025.05.08.652548"},{"key":"868_CR72","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-019-0181-9","volume":"9","author":"N Candelise","year":"2020","unstructured":"Candelise N, Schmitz M, Th\u00fcne K, Cramm M, Rabano A, Zafar S, Stoops E, Vanderstichele H, Villar-Pique A, Llorens F, Zerr I. Effect of the micro-environment on \u03b1-synuclein conversion and implication in seeded conversion assays. Translational Neurodegeneration. 2020;9:5.","journal-title":"Translational Neurodegeneration"},{"key":"868_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105807","volume":"117","author":"FB Gomes","year":"2023","unstructured":"Gomes FB, Farris MC, Ma Y, Concha-Marambio L, Lebovitz R, Nellg\u00e5rd B, Dalla K, Constantinescu J, Constantinescu R, Gobom J, et al. \u03b1-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders. Parkinsonism Relat Disord. 2023;117: 105807.","journal-title":"Parkinsonism Relat Disord"},{"key":"868_CR74","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ana.25446","volume":"85","author":"N Candelise","year":"2019","unstructured":"Candelise N, Schmitz M, Llorens F, Villar-Piqu\u00e9 A, Cramm M, Thom T, Correia SDMS, Cunha DGEJ, M\u00f6bius W, Outeiro FT, et al. Seeding variability of different alpha synuclein strains in synucleinopathies. Ann Neurol. 2019;85:691\u2013703.","journal-title":"Ann Neurol"},{"key":"868_CR75","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/brain\/awab431","volume":"145","author":"I Poggiolini","year":"2022","unstructured":"Poggiolini I, Gupta V, Lawton M, Lee S, El-Turabi A, Querejeta-Coma A, Trenkwalder C, Sixel-Doring F, Foubert-Samier A, Pavy-Le Traon A, et al. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies. Brain. 2022;145:584\u201395.","journal-title":"Brain"},{"key":"868_CR76","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-022-02421-8","volume":"143","author":"Y Jin","year":"2022","unstructured":"Jin Y, Li F, Sonoustoun B, Kondru NC, Martens YA, Qiao W, Heckman MG, Ikezu TC, Li Z, Burgess JD, et al. APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology. Acta Neuropathol. 2022;143:641\u201362.","journal-title":"Acta Neuropathol"},{"key":"868_CR77","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, et al. Assessment of heterogeneity among participants in the Parkinson\u2019s progression markers initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 2023;22:407\u201317.","journal-title":"Lancet Neurol"},{"key":"868_CR78","first-page":"3916","volume":"55","author":"K Sano","year":"2018","unstructured":"Sano K, Atarashi R, Satoh K, Ishibashi D, Nakagaki T, Iwasaki Y, Yoshida M, Murayama S, Mishima K, Nishida N. Prion-like seeding of misfolded \u03b1-Synuclein in the brains of dementia with Lewy body patients in RT-QUIC. Mol Neurobiol. 2018;55:3916\u201330.","journal-title":"Mol Neurobiol"},{"key":"868_CR79","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/ana.26089","volume":"89","author":"W Singer","year":"2021","unstructured":"Singer W, Schmeichel AM, Shahnawaz M, Schmelzer JD, Sletten DM, Gehrking TL, Gehrking JA, Olson AD, Suarez MD, Misra PP, et al. Alpha-synuclein oligomers and neurofilament light chain predict phenoconversion of pure autonomic failure. Ann Neurol. 2021;89:1212\u201320.","journal-title":"Ann Neurol"},{"key":"868_CR80","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00401-025-02872-9","volume":"149","author":"H Sekiya","year":"2025","unstructured":"Sekiya H, Franke L, Hashimoto Y, Takata M, Nishida K, Futamura N, Hasegawa K, Kowa H, Ross OA, McLean PJ, et al. Widespread distribution of \u03b1-synuclein oligomers in LRRK2-related Parkinson\u2019s disease. Acta Neuropathol. 2025;149:42.","journal-title":"Acta Neuropathol"},{"key":"868_CR81","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00401-025-02871-w","volume":"149","author":"NM Jensen","year":"2025","unstructured":"Jensen NM, Vitic Z, Antorini MR, Viftrup TB, Parkkinen L, Jensen PH. Abundant non-inclusion \u03b1-synuclein pathology in Lewy body-negative LRRK2-mutant cases. Acta Neuropathol. 2025;149:41.","journal-title":"Acta Neuropathol"},{"key":"868_CR82","doi-asserted-by":"publisher","first-page":"e1944","DOI":"10.1212\/WNL.0000000000207147","volume":"100","author":"A Iranzo","year":"2023","unstructured":"Iranzo A, Mammana A, Mu\u00f1oz-Lopetegi A, Dellavalle S, May\u00e0 G, Rossi M, Serradell M, Baiardi S, Arqueros A, Quadalti C, et al. Misfolded \u03b1-Synuclein assessment in the skin and CSF by RT-QuIC in isolated REM sleep behavior disorder. Neurology. 2023;100:e1944\u201354.","journal-title":"Neurology"},{"key":"868_CR83","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/mds.29329","volume":"38","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L, Weber S, Farris CM, Dakna M, Lang E, Wicke T, Ma Y, Starke M, Ebentheuer J, Sixel-D\u00f6ring F, et al. Accurate detection of \u03b1-Synuclein seeds in cerebrospinal fluid from isolated rapid eye movement sleep behavior disorder and patients with Parkinson\u2019s disease in the DeNovo Parkinson (DeNoPa) cohort. Mov Disord. 2023;38:567\u201378.","journal-title":"Mov Disord"},{"key":"868_CR84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41531-023-00627-5","volume":"10","author":"K Brockmann","year":"2024","unstructured":"Brockmann K, Lerche S, Baiardi S, Rossi M, Wurster I, Quadalti C, Roeben B, Mammana A, Zimmermann M, Hauser AK, et al. CSF \u03b1-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2024;10:24.","journal-title":"NPJ Parkinsons Dis"},{"key":"868_CR85","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s40478-023-01653-3","volume":"11","author":"S Br\u00e4uer","year":"2023","unstructured":"Br\u00e4uer S, Rossi M, Sajapin J, Henle T, Gasser T, Parchi P, Brockmann K, Falkenburger BH. Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders. Acta Neuropathol Commun. 2023;11:162.","journal-title":"Acta Neuropathol Commun"},{"key":"868_CR86","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.27907","volume":"35","author":"S Manne","year":"2020","unstructured":"Manne S, Kondru N, Jin H, Anantharam V, Huang X, Kanthasamy A, Kanthasamy AG. \u03b1-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson\u2019s disease patients. Mov Disord. 2020;35:268\u201378.","journal-title":"Mov Disord"},{"key":"868_CR87","doi-asserted-by":"publisher","first-page":"e2513","DOI":"10.1212\/WNL.0000000000011935","volume":"96","author":"V Donadio","year":"2021","unstructured":"Donadio V, Wang Z, Incensi A, Rizzo G, Fileccia E, Vacchiano V, Capellari S, Magnani M, Scaglione C, Maserati SM, et al. In vivo diagnosis of synucleinopathies. Neurology. 2021;96:e2513\u201324.","journal-title":"Neurology"},{"key":"868_CR88","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","volume":"29","author":"A Okuzumi","year":"2023","unstructured":"Okuzumi A, Hatano T, Matsumoto G, Nojiri S, Ueno SI, Imamichi-Tatano Y, Kimura H, Kakuta S, Kondo A, Fukuhara T, et al. Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med. 2023;29:1448\u201355.","journal-title":"Nat Med"},{"key":"868_CR89","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2024.0792","volume":"331","author":"CH Gibbons","year":"2024","unstructured":"Gibbons CH, Levine T, Adler C, Bellaire B, Wang N, Stohl J, Agarwal P, Aldridge GM, Barboi A, Evidente VGH, et al. Skin biopsy detection of phosphorylated \u03b1-Synuclein in patients with synucleinopathies. JAMA. 2024;331:1298\u2013306.","journal-title":"JAMA"},{"key":"868_CR90","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/jnen\/nlae015","volume":"83","author":"V Donadio","year":"2024","unstructured":"Donadio V, Fadda L, Incensi A, Furia A, Parisini S, Colaci F, Defazio G, Liguori R. Skin nerve phosphorylated \u03b1-synuclein in the elderly. J Neuropathol Exp Neurol. 2024;83:245\u201350.","journal-title":"J Neuropathol Exp Neurol"},{"key":"868_CR91","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","volume":"5","author":"R Barbour","year":"2008","unstructured":"Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, Fox M, Goldstein JM, Soriano F, Seubert P, Chilcote TJ. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis. 2008;5:55\u20139.","journal-title":"Neurodegener Dis"},{"key":"868_CR92","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-023-00613-8","volume":"18","author":"G Bellomo","year":"2023","unstructured":"Bellomo G, Paciotti S, Concha-Marambio L, Rizzo D, Wojda\u019aa AL, Chiasserini D, Gatticchi L, Cerofolini L, Giuntini S, De Luca CMG, et al. Cerebrospinal fluid lipoproteins inhibit \u03b1-synuclein aggregation by interacting with oligomeric species in seed amplification assays. Mol Neurodegener. 2023;18:20.","journal-title":"Mol Neurodegener"},{"key":"868_CR93","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1021\/acs.nanolett.4c03768","volume":"24","author":"PR Christenson","year":"2024","unstructured":"Christenson PR, Jeong H, Li M, Ahn H, Schmeichel AM, Misra P, Li D, Savica R, Low PA, Singer W, et al. Blood-based nanoparticle-enhanced quaking-induced conversion (Nano-QuIC): inhibitor-resistant detection of seeding activity in patients diagnosed with Parkinson\u2019s disease. Nano Lett. 2024;24:15016\u201324.","journal-title":"Nano Lett"},{"key":"868_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105256","volume":"151","author":"A Dominguez-Meijide","year":"2021","unstructured":"Dominguez-Meijide A, Parrales V, Vasili E, Gonz\u00e1lez-Liz\u00e1rraga F, K\u00f6nig A, L\u00e1zaro FD, Lannuzel A, Haik S, Bel DE, Cheh\u00edn R, et al. Doxycycline inhibits \u03b1-synuclein-associated pathologies in vitro and in vivo. Neurobiol Dis. 2021;151: 105256.","journal-title":"Neurobiol Dis"},{"key":"868_CR95","doi-asserted-by":"publisher","first-page":"eadk3700","DOI":"10.1126\/sciadv.adk3700","volume":"10","author":"Y Jin","year":"2024","unstructured":"Jin Y, Li F, Li Z, Ikezu TC, O\u2019Leary J, Selvaraj M, Zhu Y, Martens YA, Koga S, Santhakumar H. Modeling Lewy body disease with SNCA triplication iPSC-derived cortical organoids and identifying therapeutic drugs. Sci Adv. 2024;10:eadk3700.","journal-title":"Sci Adv"},{"key":"868_CR96","doi-asserted-by":"crossref","unstructured":"Cukierman SD, Pinheiro BA, Casti\u00f1eiras-Filho LPS, Silva DPSA, Miotto CM, Falco DA, Ribeiro PDT, Maisonette S, Cunha DLMCA, Hauser-Davis AR, et al. A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies. J Inorg Biochem 2017;170:160\u2013168.","DOI":"10.1016\/j.jinorgbio.2017.02.020"},{"key":"868_CR97","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/acn3.51753","volume":"10","author":"LM Chahine","year":"2023","unstructured":"Chahine LM, Beach TG, Adler CH, Hepker M, Kanthasamy AG, Appel S, Pritzkow S, Pinho M, Mosovsky S, Serrano GE, et al. Central and peripheral \u0391-synuclein in Parkinson disease detected by seed amplification assay. Ann Clin Transl Neurol. 2023;10:696\u2013705.","journal-title":"Ann Clin Transl Neurol"},{"key":"868_CR98","doi-asserted-by":"crossref","unstructured":"Bellomo G, Chiara Maria Giulia De L, Paoletti FP, Gaetani L, Moda F, Parnetti L. \u0391-Synuclein seed amplification assays for diagnosing synucleinopathies. Neurology 2022;99:195-205","DOI":"10.1212\/WNL.0000000000200878"},{"key":"868_CR99","doi-asserted-by":"publisher","first-page":"872629","DOI":"10.3389\/fnagi.2022.872629","volume":"14","author":"T Coysh","year":"2022","unstructured":"Coysh T, Mead S. The future of seed amplification assays and clinical trials. Front Aging Neuroscience. 2022;14:872629.","journal-title":"Front Aging Neuroscience"},{"key":"868_CR100","doi-asserted-by":"publisher","first-page":"23029","DOI":"10.1073\/pnas.1909322116","volume":"116","author":"MA Metrick","year":"2019","unstructured":"Metrick MA, Ferreira NDC, Saijo E, Hughson AG, Kraus A, Orr\u00fa CD, Miller MW, Zanusso G, Ghetti B, Vendruscolo M, Caughey B. Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister Ion comparisons. Proc Natl Acad Sci. 2019;116:23029\u201339.","journal-title":"Proc Natl Acad Sci"},{"key":"868_CR101","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/mds.27646","volume":"34","author":"UJ Kang","year":"2019","unstructured":"Kang UJ, Boehme AK, Fairfoul G, Shahnawaz M, Ma T, Hutten SJ, Green A, Soto C. Comparative study of cerebrospinal fluid \u0391-synuclein seeding aggregation assays for diagnosis of Parkinson\u2019s disease. Mov Disord. 2019;34:536\u201344.","journal-title":"Mov Disord"},{"key":"868_CR102","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1515\/cclm-2023-1472","volume":"62","author":"A Mammana","year":"2024","unstructured":"Mammana A, Baiardi S, Rossi M, Quadalti C, Ticca A, Magliocchetti F, Bernhardt A, Capellari S, Parchi P. Improving protocols for \u03b1-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification. Clin Chem Lab Med (CCLM). 2024;62:2001\u201310.","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"868_CR103","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.3390\/ijms25115988","volume":"25","author":"C Janarthanam","year":"2024","unstructured":"Janarthanam C, Clabaugh G, Wang Z, Melvin BR, Scheibe I, Jin H, Anantharam V, Urbauer RJB, Urbauer JL, Ma J, et al. High-yield \u03b1-Synuclein purification and ionic strength modification pivotal to seed amplification assay performance and reproducibility. Int J Mol Sci. 2024;25:5988.","journal-title":"Int J Mol Sci"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00868-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00868-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00868-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:04:18Z","timestamp":1751364258000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00868-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00868-3","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}